Vice President of Quality
Atara Biotherapeutics, Inc. is a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation, with an initial focus on immunotherapy and oncology. Atara Bio's programs include T-cell product candidates and molecularly targeted product candidates. The T-cell product candidates include EBV-CTL, CMV-CTL, and Wilms Tumor 1 targeted Cytotoxic T-cells (WT1-CTL) and harness the power of the immune system to recognize and attack cancer cells and cells infected with certain viruses. The molecularly targeted product candidates include STM 434. These product candidates target activin and myostatin, members of the TGF-beta family of proteins, and have demonstrated the potential to have therapeutic benefit in a number of clinical indications.
I have held leadership positions of increasing responsibility in quality, supporting cell and gene therapy, aseptic fill/finish, biologics and vaccine sites, including six start-up operations for both clinical and commercial manufacturing. My 25+ years of experience includes quality systems, product quality, supplier management, investigations, aseptic processing, sterility assurance and quality control testing across all stages of product development.
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of Tara Raab at Atara Biotherapeutics then you’ve come to the right place.
Wondering if it's tara@atarabio.com, tara.raab@atarabio.com, raab@atarabio.com, or traab@atarabio.com? We have the answers for you.